More alarm for Wockhardt, FDA raises concern over US unit

May 27 2014, 15:55 IST
Comments 0
US FDA has expressed concerns over production processes at the US unit of Wockhardt Ltd. US FDA has expressed concerns over production processes at the US unit of Wockhardt Ltd.
SummaryUS is Wockhardt's biggest market and FDA has already banned import of its drugs.

issued a "restricted" license on Wockhardt's Waluj and Chikalthana plants and on another one of its India-based sites, allowing Wockhardt to export only a limited range of drugs from those sites.

"The MHRA have been back to re-inspect (Chikalthana plant) and the situation remains as before," MHRA spokesman Nick Spears said in a statement emailed to Reuters on Friday.

Khorakiwala said the British agency observed it was "seeing signs of improvement in various areas" at the Chikalthana plant.

Wockhardt is working towards moving production from the Waluj and Chikalthana plants to its other sites, a move Khorakiwala expected to be complete next year.

On Tuesday, shares in Mumbai-based Wockhardt were trading down 4.5 percent at 0822 GMT, having fallen as much as 8.7 percent earlier, while the broader Mumbai market index was down nearly 1 percent.

($1 = 58.3575 Indian Rupees)

Single Page Format
Ads by Google

More from FE editor's picks

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...